Patient Resources
Get Healthy!
Results for search "Weight Loss".
Health Videos - 9
Intermittent Fasting Falls Short for Weight Loss, Major Review Finds
A large, new evidence review finds intermittent fasting may not help overweight or obese patients loose a significant amount of weight or improve their quality of life.
GLP-1 Weight-Loss Drugs Tied to Increased Risk of Hair Loss
A large, new study finds adults who use GLP-1 medications face higher odds of a common form of hair shedding, as well as male or female pattern baldness.
GLP-1 Weight-Loss Drugs Are Changing What Americans Buy to Eat
A new study finds when people start taking GLP-1 medications, spending at grocery stores and restaurants changes.
GLP-1 Medications in Kids: Promising Health Results, Ongoing Safety Concerns
A new study finds children and teens with obesity or diabetes who take GLP-1 weight-loss medications experience significant improvements in many cardiometabolic risk factors, but long-term safety questions remain.
Does Losing Weight Before IVF Improve Chances For Pregnancy?
A new study finds women with obesity who lose weight before IVF have increased odds of getting pregnant, especially through natural conception.
Ditching Ultra-Processed Food Helps Move the Scale Faster
In a new study, people lost twice as much weight on a diet with minimally processed foods compared to one with ultra-processed foods.
Weight Returns Within Months Of Stopping Anti-Obesity Drugs, Study Finds
People who quit taking anti-obesity meds, including popular GLP-1 receptor agonists, may regain a significant amount of weight after eight weeks, a new study finds.
Popular Weight-Loss Drugs Produce Less Weight Loss in Real-World Settings, Study Finds
Patients with obesity who take GLP-1 receptor agonists in real-world settings lose significantly less weight than participants in randomized clinical trials, according to new research.
Intermittent Fasting Leads to Greater Weight Loss Than Calorie Counting, New Study Finds
Overweight and obese adults who followed a 4:3 intermittent fasting plan dropped more pounds in one year than those who counted calories.
Health News Results - 249
Heart Benefits From GLP-1 Drugs Fade After Stopping, Study Finds
- HealthDay Staff HealthDay Reporter
- March 20, 2026
- Full Page
FRIDAY, March 20, 2026 (HealthDay News) — Drugs like Ozempic and Mounjaro are known to lower the risk of heart attack and stroke...
U.S. Teen Obesity Hits Record Highs While Efforts to Slim Down Drop
- Deanna Neff HealthDay Reporter
- March 19, 2026
- Full Page
THURSDAY, March 19, 2026 (HealthDay News) — Late-night study sessions and the constant hum of social media make high school a stressful time, and a new study suggests that stress is contributing to a growing weight and health crisis.
Researchers from Florida Atlant...
AI-Generated Meal Plans For Dieting Teens Could Be Harmful, Study Warns
- Dennis Thompson HealthDay Reporter
- March 13, 2026
- Full Page
FRIDAY, March 13, 2026 (HealthDay News) — Many teens are turning to artificial intelligence (AI) chatbots to help them lose weight by crafting meal plans for dieting.
But a new study warns that those plans are more likely to lead to malnutrition and eating disorder...
FDA Warns Novo Nordisk Broke Safety Reporting Rules
- HealthDay Staff HealthDay Reporter
- March 12, 2026
- Full Page
THURSDAY, March 12, 2026 (HealthDay News) — Federal regulators have warned the maker of Ozempic and Wegovy that it failed to report possible drug side effects to the government.<...
Switching GLP-1 Medications Is Common, Can Help People Stick With Weight-Loss Treatment
- Dennis Thompson HealthDay Reporter
- March 12, 2026
- Full Page
THURSDAY, March 12, 2026 (HealthDay News) — People frequently switch between different weight-loss drugs, swapping Ozempic for Zepbo...
Lowering Parents' Stress Can Reduce Risk Of Childhood Obesity
- Dennis Thompson HealthDay Reporter
- March 11, 2026
- Full Page
WEDNESDAY, March 11, 2026 (HealthDay News) — Providing support to stressed-out parents might help their children avoid obesity, a new study says.
Children were more likely to eat healthy and not gain weight if their parents participated in training to help manage <...
Weighted Vests Help Keep Bones Strong — But Only If Seniors Stay Active
- Dennis Thompson HealthDay Reporter
- March 9, 2026
- Full Page
MONDAY, March 9, 2026 (HealthDay News) — Weighted vests – the latest internet-driven workout craze – can help older folks improve their bone health while losing weight, a new study says.
There's one caveat though: The vest won’t help your bones if...
Some Patients Keep Weight off With Fewer GLP-1 Injections, Study Finds
- HealthDay Staff HealthDay Reporter
- March 6, 2026
- Full Page
FRIDAY, March 6, 2026 (HealthDay News) — Some patients taking popular GLP-1 weight loss drugs may be able to keep the weight off while taking injections less ofte...
GLP-1 Weight-Loss Drugs Prove Effective Across Diverse Patient Groups
- Deanna Neff HealthDay Reporter
- March 6, 2026
- Full Page
FRIDAY, March 6, 2026 (HealthDay News) — As the popularity of medications like Ozempic and Trulicity for losing weight continues to soar, folks may wonder: "Will they work...
Novo Nordisk Cuts Prices of Ozempic and Wegovy Starting January 2027
- HealthDay Staff HealthDay Reporter
- February 25, 2026
- Full Page
WEDNESDAY, Feb. 25, 2026 (HealthDay News) — Some of the most popular diabetes and weight-loss drugs in the U.S. will soon cost a lot less.
Novo Nordisk announced Tuesday that it will cut U.S. list prices of
Results Outweigh Side Effects Among Ozempic/Wegovy Users, Study Says
- Dennis Thompson HealthDay Reporter
- February 23, 2026
- Full Page
MONDAY, Feb. 23, 2026 (HealthDay News) — Side effects like nausea or vomiting are common among folks taking Ozempic/Wegovy, but they’ll grin and bear it if they think they&...
Hims Pulls Cheaper Wegovy Pill After Federal Scrutiny
- I. Edwards HealthDay Reporter
- February 9, 2026
- Full Page
MONDAY, Feb. 9, 2026 (HealthDay News) — Hims & Hers says it will stop selling a low-cost copy of a new weight-loss pill made by Novo Nordisk, after federal officials raised concerns that t...
GLP-1 Medications: A Comprehensive Overview
- Reema?Dbouk, MD, FACP, Assistant Professor of Medicine at Emory University School of Medicine HealthDay Reporter
- January 22, 2026
- Full Page
THURSDAY, Jan. 22, 2026 (HealthDay News) — With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabet...
FDA Moves To Remove Suicide Warnings From GLP-1 Weight Loss Drugs
- I. Edwards HealthDay Reporter
- January 15, 2026
- Full Page
THURSDAY, Jan. 15, 2026 (HealthDay News) — Federal health regulators say popular weight loss drugs like Wegovy and Zepbound do not increase the risk of suicidal thoughts, an...
Weight Often Returns After Stopping Ozempic, Wegovy, Study Finds
- I. Edwards HealthDay Reporter
- January 9, 2026
- Full Page
FRIDAY, Jan. 9, 2026 (HealthDay News) — People who stop taking popular weight loss drugs like Ozempic and Wegovy are likely to gain the weight back, and sooner than many expect, a new study finds.
Researchers reviewed dozens of earlier studies and found that most p...
Poll Shows Most Americans Want to Slim Down
- Deanna Neff HealthDay Reporter
- January 7, 2026
- Full Page
WEDNESDAY, Jan. 7, 2026 (HealthDay News) — As the New Year’s resolutions take center stage, a new nationwide poll shows that while a majority of American adults want to be thinner, only a fraction are doing anything about it.
In all, 52% of Americans want to ...
Novo Nordisk Launches Daily Weight-Loss Pill to Expand GLP-1 Access
- I. Edwards HealthDay Reporter
- January 6, 2026
- Full Page
TUESDAY, Jan. 6, 2026 (HealthDay News) — A daily pill for weight loss has officially arrived in the U.S.
On Monday, Novo Nordisk rolled out the first GLP-1 weight-loss pill, an oral version of Wegovy.
The compa...
How to Fight 'Middle-Age Spread'
- Carole Tanzer Miller HealthDay Reporter
- December 26, 2025
- Full Page
FRIDAY, Dec. 26, 2025 (HealthDay News) — A steady uptick on your scale is a nasty side effect of middle age.
Most adults in the U.S. put on 10 to 25 pounds between their 20s and their 40s — and there’s more bad news about this "middle-age spread."
GLP-1 Medications Show Little Effect on Cancer, Study Shows
- I. Edwards HealthDay Reporter
- December 10, 2025
- Full Page
WEDNESDAY, Dec. 10, 2025 (HealthDay News) — A new study suggests popular GLP-1 drugs, like Ozempic and Zepbound, may not lower c...
Eli Lilly Becomes First Trillion-Dollar Health Company
- I. Edwards HealthDay Reporter
- November 24, 2025
- Full Page
MONDAY, Nov. 24, 2025 (HealthDay News) — Eli Lilly reached a major milestone Friday, becoming the first healthcare company in the world to hit a $1 trillion market value.
The drug company briefly crossed the trillion-dollar mark...
Staying Slim: What’s More Effective, Exercise or Healthy Eating?
- Ernie Mundell HealthDay Reporter
- November 24, 2025
- Full Page
MONDAY, Nov. 24, 2025 (HealthDay News) — When it comes to warding off excess fat, boosting exercise levels while improving your diet may be most effective, rather than focusing on either exercise or diet alone.
That’s the finding from a seven-year study of al...
Novo Nordisk Rolls Out Lower Prices for Ozempic and Wegovy
- I. Edwards HealthDay Reporter
- November 19, 2025
- Full Page
WEDNESDAY, Nov. 19, 2025 (HealthDay News) — People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk...
Trump Announces Major Price Cut for Ozempic, Wegovy and Similar Drugs
- I. Edwards HealthDay Reporter
- November 7, 2025
- Full Page
FRIDAY, Nov. 7, 2025 (HealthDay News) — Two major drugmakers will slash the price of popular weight loss medications for some Americans, including people on Medicare and Medicaid, President Donald Trump<...
The Way A Man Loses Weight Matters To His Fertility, Review Says
- Dennis Thompson HealthDay Reporter
- November 5, 2025
- Full Page
WEDNESDAY, Nov. 5, 2025 (HealthDay News) — Losing weight is considered one way to improve male fertility, but how guys drop pounds also matters, a new evidence review says.
Men who lost weight through diet and exercise did wind up with better sperm quality, even wi...
Costco To Sell Ozempic and Wegovy for $499 a Month
- I. Edwards HealthDay Reporter
- October 6, 2025
- Full Page
MONDAY, Oct. 6, 2025 (HealthDay News) — Costco shoppers will be able fill prescriptions for Ozempic and Wegovy — two of the most popular weight loss and diabetes drugs — at a discount.
Novo Nordisk, the maker o...
.jpg?w=1920&h=1080&mode=crop&crop=focalpoint)
Mouse Study Offers Cautionary Tale About The Keto Diet
- Carole Tanzer Miller HealthDay Reporter
- September 28, 2025
- Full Page
SUNDAY, Sept. 28, 2025 (HealthDay News) — It sounds counterintuitive: Eat more fat and lose more weight.
But it’s the underpinning of a keto diet — a controversial eating regimen designed to retrain the body to rely on something other than sugar for en...
Ozempic Pill Effective For Weight Loss
- Dennis Thompson HealthDay Reporter
- September 24, 2025
- Full Page
WEDNESDAY, Sept. 24, 2025 (HealthDay News) — A pill form of the blockbuster weight-loss drug Ozempic can help overweight or obese folks shed excess pounds, a new clinical trial h...
Weight-Loss Surgery Outperforms GLP-1 Drugs, Study Argues
- Dennis Thompson HealthDay Reporter
- September 19, 2025
- Full Page
FRIDAY, Sept. 19, 2025 (HealthDay News) — Cutting-edge drugs like Ozempic and Zepbound are all the rage for dropping excess poun...
Wegovy May Help Quiet Constant Food Cravings, Study Finds
- I. Edwards HealthDay Reporter
- September 17, 2025
- Full Page
WEDNESDAY, Sept. 17, 2025 (HealthDay News) — A popular weight-loss drug may do more than help patients shed pounds. It could also help quiet the nonstop food cravings many people struggle with.
New GLP-1 Pill Helps People Lose 23 Pounds in Study
- I. Edwards HealthDay Reporter
- August 27, 2025
- Full Page
WEDNESDAY, Aug. 27, 2025 (HealthDay News) — Eli Lilly says its new once-daily pill, orforglipron, helped people lose significant weight and lower blood sugar in a late-stag...
New Weight Loss Pill From Eli Lilly Shows Promise in Early Study
- I. Edwards HealthDay Reporter
- August 8, 2025
- Full Page
FRIDAY, Aug. 8, 2025 (HealthDay News) — A new weight loss pill made by Eli Lilly helped people lose a significant amount of weight in a recent study.
1 in 10 Americans Has Used GLP-1 Drugs For Weight Loss, Survey Says
- Dennis Thompson HealthDay Reporter
- August 8, 2025
- Full Page
FRIDAY, Aug. 8, 2025 (HealthDay News) — More than 1 in 10 Americans have used a GLP-1 drug for weight loss, a new survey by the RAND research group reveals.
About 12% say they&...
Experts Recommend Healthy Lifestyle Changes Alongside GLP-1 Drug Use
- HealthDay Reporter
- Dennis Thompson
- July 16, 2025
- Full Page
WEDNESDAY, July 16, 2025 (HealthDay News) — GLP-1 weight-loss drugs like Ozempic and Zepbound are so effective it might seem that a person can lose weight without doing anything ...
Menopause Hormone Therapy Boosts GLP-1 Drug Effectiveness, Researchers Say
- HealthDay Reporter
- Dennis Thompson
- July 14, 2025
- Full Page
MONDAY, July 14, 2025 (HealthDay News) — Good news for women of a certain age: Hormone replacement therapy for menopause appears to boost the effe...
Monthly Obesity Shot Shows Big Weight Loss in Trial
- HealthDay Reporter
- Carole Tanzer Miller
- June 25, 2025
- Full Page
WEDNESDAY, June 25, 2025 (HealthDay News) — Alternatives to weekly injections of weight-loss drugs may on the way.
A monthly dose of a new drug called MariTide helped participants in a phase 2 clinical trial shed about 20% of their body weight over a year, research...
Weighted Vests Don't Protect Bone Health In Dieting Seniors, Trial Says
- HealthDay Reporter
- Dennis Thompson
- June 24, 2025
- Full Page
TUESDAY, June 24, 2025 (HealthDay News) — Weighted vests have been touted as a potential means of warding off osteoporosis while losing weight.
The idea is that the...
Rival GLP-1 Weight-Loss Drug Emerges From China
- HealthDay Reporter
- Dennis Thompson
- June 24, 2025
- Full Page
TUESDAY, June 24, 2025 (HealthDay News) — A new Chinese-developed GLP-1 weight loss drug could prove a new competitor to blockbuster drugs Ozempic/Wegovy and
Trading Diet Sodas For Water Can Help Control Diabetes And Lose Weight
- HealthDay Reporter
- Dennis Thompson
- June 23, 2025
- Full Page
MONDAY, June 23, 2025 (HealthDay News) — Want to lose weight and reverse type 2 diabetes?
Trade your diet soda for a tall glass of water, a new small-scale study argues.
An Expert's Guide to Keeping Middle-Age Spread at Bay
- HealthDay Reporter
- Carole Tanzer Miller
- June 7, 2025
- Full Page
SATURDAY, June 7, 2025 (HealthDay News) — You're not just getting older, you're probably getting bigger.
Between their 20s and 40s, most Americans can expect to put on 10 to 25 pounds — and after 30, exercise may not have the same payoff it once did.
More U.S. Teens Are Now Taking Wegovy for Weight Loss
- HealthDay Reporter
- I. Edwards
- June 5, 2025
- Full Page
THURSDAY, June 5, 2025 (HealthDay News) — More American teenagers now use the weight-loss drug Wegovy, as doctors and families grow more comfortable with the treatment.
But experts say access is still limited, and more research on its long-term safety in teen...
Weight Stigma Tied To Lingering Depression, Anxiety After Weight-Loss Surgery
- HealthDay Reporter
- Dennis Thompson
- June 5, 2025
- Full Page
THURSDAY, June 5, 2025 (HealthDay News) — People who get weight-loss surgery experience an improvement in their mental health, but not because of the weight they lose, a new study says.
Rather, these patients face much less societal stigma over their weight, and it...
Shedding Pounds in Middle Age Could Add Years to Your Life, Study Finds
- HealthDay Reporter
- I. Edwards
- May 28, 2025
- Full Page
WEDNESDAY, May 28, 2025 (HealthDay News) — Losing just 6.5% of body weight in midlife may lower later risk of disease and premature death, new research shows.
Researchers found that people who lost about 6.5% of their body weight — without using weight loss d...
FDA Halts Sale of Off-Brand Ozempic and Other GLP-1 Drugs
- HealthDay Reporter
- I. Edwards
- May 23, 2025
- Full Page
FRIDAY, May 23, 2025 (HealthDay News) — A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on....
GLP-1 Weight Loss Drugs Cut Alcohol Cravings By Two-Thirds
- HealthDay Reporter
- Dennis Thompson
- May 13, 2025
- Full Page
Cutting-edge weight-loss drugs like Ozempic/Wegovy can cut alcohol intake dramatically in a short amount of time, a new study says.
<...
Zepbound Outperforms Wegovy in Head-to-Head Weight Loss Study
- HealthDay Reporter
- I. Edwards
- May 12, 2025
- Full Page
A new study has found that people taking Eli Lilly’s obesity drug Zepbound lost almost 50% more weight than those using Novo Nordisk’s Wegovy.
The study -- publi...
First Weight-Loss Pill From Lilly Shows Promising Results
- HealthDay Reporter
- I. Edwards
- April 18, 2025
- Full Page
A new pill designed to help with weight loss and blood sugar control is showing promise in early studies.
Eli Lilly said its experimental drug, orforglipron, helped people with
Pfizer Ends Testing of Obesity Pill After Possible Liver Injury
- HealthDay Reporter
- I. Edwards
- April 15, 2025
- Full Page
Pfizer has stopped developing a once-daily pill to treat obesity after a person in a clinical trial showed signs of a possible liver injury.
The company said the injury went away after the person stopped taking the drug, called danuglipron, The Associated Press ...
Biden Plan To Expand Obesity Drug Coverage Is Rejected
- HealthDay Reporter
- I. Edwards
- April 7, 2025
- Full Page
The Trump administration has decided not to expand Medicare and Medicaid coverage for popular obesity drugs, blocking a Biden administration initiative that could have helped millions of Americans access the medications.
Fasting Outperforms Calorie Cutting, Clinical Trial Says
- HealthDay Reporter
- Dennis Thompson
- April 1, 2025
- Full Page
Fasting every other day can prompt more weight loss than simply cutting calories, a new clinical trial shows.
People who undertook 4:3 intermittent fasting lost just under 8% of their body weight within a year, compared to a 5% loss among people who cut their daily calor...
Novo Nordisk to Pay $2 Billion for New Weight Loss Drug
- HealthDay Reporter
- I. Edwards
- March 25, 2025
- Full Page
Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity and diabetes drug, the company announced March 24.
The drug, cal...